On December 13, 2017, the Centers for Medicare & Medicaid Services (“CMS”) published subregulatory guidance to answer questions about billing for drugs acquired through the 340B Drug Pricing Program ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results